Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2016 /
Inclusion of elderly patients in clinical trials

17th - 19th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.16
Views: 1646

Olivia Le Saux - Hospices Civils de Lyon, Lyon, France

Olivia Le Saux speaks with ecancertv at SIOG 2016 about the influence of SIOG in incorporating geriatric patients into clinical trials.

She describes how, after the founding of the organisation, elderly specific endpoints are not used as often as the increase in geriatric subgroups would suggest.

Comparing composite endpoints and co-primary endpoints, she also considers the balance of quality of life and life extension as trial outcomes.

This service has been kindly supported by an unrestricted grant from Merck/MSD.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation